Time to eradicate HTLV-1: an open letter to WHO

F Martin, Y Tagaya, R Gallo - The Lancet, 2018 - thelancet.com
Human T-cell leukaemia virus 1 (HTLV-1) is the most potent carcinogenic oncovirus and
potentially the most oncogenic risk factor including chem ical carcinogens. 1 A unique and …

[引用][C] Time to eradicate HTLV-1: an open letter to WHO

F Martin, Y Tagaya, R Gallo - The Lancet, 2018 - cir.nii.ac.jp

[引用][C] Time to eradicate HTLV-1: an open letter to WHO.

F Martin, Y Tagaya, R Gallo - Lancet (London, England), 2018 - europepmc.org
Time to eradicate HTLV-1: an open letter to WHO. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

[PDF][PDF] Time to eradicate HTLV-1: an open letter to WHO

F Martin, Y Tagaya, R Gallo - Proc Natl Acad Sci USA, 1980 - shsqld.com
Human T-cell leukaemia virus 1 (HTLV-1) is the most potent carcinogenic oncovirus and
potentially the most oncogenic risk factor including chem ical carcinogens. 1 A unique and …

Time to eradicate HTLV-1: an open letter to WHO

F Martin, Y Tagaya, R Gallo - Lancet (London, England), 2018 - pubmed.ncbi.nlm.nih.gov
Time to eradicate HTLV-1: an open letter to WHO Time to eradicate HTLV-1: an open letter to
WHO Lancet. 2018 May 12;391(10133):1893-1894. doi: 10.1016/S0140-6736(18)30974-7 …

[引用][C] Time to eradicate HTLV-1: an open letter to WHO

F Martin, Y Tagaya, R Gallo - The Lancet, 2018 - espace.library.uq.edu.au